Kanabidiol (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kanabidiol" in Slovenian language version.

refsWebsite
Global rank Slovenian rank
447th place
409th place
4th place
8th place
1st place
2nd place
2nd place
5th place
low place
8,757th place
low place
8,758th place
low place
4,682nd place
2,393rd place
1,035th place
68th place
28th place

doi.org

europa.eu

ema.europa.eu

fda.gov

  • »FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer's disease, opioid withdrawal, pain and pet anxiety«. US Food and Drug Administration (FDA). 23. julij 2019. Arhivirano iz spletišča dne 14. avgusta 2019. Pridobljeno 24. julija 2019. Unlike drugs approved by the FDA, the manufacturing process of these products has not been subject to FDA review as part of the drug approval process, and there has been no FDA evaluation of whether these products are effective for their intended use, what the proper dosage is, how they could interact with FDA-approved drugs, or whether they have dangerous side effects or other safety concerns.
  • »FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy«. fda.gov. Pridobljeno 28. marca 2022.

hempembassy.it

  • »THC e CBD«. hempembassy.it (v italijanščini). 23. april 2023.

mayoclinicproceedings.org

nih.gov

ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov

openaccessgovernment.org

thelancet.com

web.archive.org

  • »FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer's disease, opioid withdrawal, pain and pet anxiety«. US Food and Drug Administration (FDA). 23. julij 2019. Arhivirano iz spletišča dne 14. avgusta 2019. Pridobljeno 24. julija 2019. Unlike drugs approved by the FDA, the manufacturing process of these products has not been subject to FDA review as part of the drug approval process, and there has been no FDA evaluation of whether these products are effective for their intended use, what the proper dosage is, how they could interact with FDA-approved drugs, or whether they have dangerous side effects or other safety concerns.